value-based care

Fewer Palliative Radiotherapy Treatments for Bone Metastases Shorten Hospital Stays Without Sacrificing Pain Relief

12/18/2015

JCP Editors

Fewer radiation treatments for bone metastases in patients with stage IV or incurable cancer can improve patient care while reducing the length of hospital stay, according to a study presented at the Palliative Care...

Fewer...

12/18/2015

Journal of Clinical Pathways

Counterpoint

When Determining Value in Cancer Care, Don`t Forget the Patient

12/14/2015

Joan S. McClure, MS

Al B. Benson III, MD, FACP, FASCO

Before the relative value of a drug can be determined, one must first consider how value is defined by the patient. Cancer care is expensive, and evaluating costs in cancer care is complex. Drug costs are only part...

Before...

12/14/2015

Journal of Clinical Pathways

Clinical Pathways GPS

The Place for Biosimilars in Clinical Pathways

12/14/2015

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Scott Guerin, PhD

Payers and at-risk providers are developing clinical pathways with great specificity regarding the preferred drugs that be used. Increasingly, these pathways will include biosimilar products. There are three major...

Payers...

12/14/2015

Journal of Clinical Pathways

Interview

A Clinical Pathway for Transcatheter Aortic Valve Replacement

12/14/2015

More and more, various health care institutions around the country are implementing clinical pathways in an effort to improve outcomes and control costs. A 2003 study reported that more than 80% of hospitals had implemented clinical...

More and more, various...

12/14/2015

Journal of Clinical Pathways

Interview

Evidence Blocks to Evaluate the Relative Value of Oncology Treatments

12/14/2015

Many institutions and health care professionals have been aware of the staggering rise of health care costs. An IMS Health report published in May of 2015 confirmed that drug sales in the United States surpassed $100...

Many...

12/14/2015

Journal of Clinical Pathways

Research in Review

Genomic Testing Can Impact Treatment Decisions, Lower Cost for Younger Breast Cancer Patients

12/02/2015

JCP Editors

Use of the 21-gene recurrence score assay (RS) can help to reduce health care spending and improve breast cancer treatment, but the extent of the benefit offered differs between younger women and those aged 75 years...

Use of...

12/02/2015

Journal of Clinical Pathways

Evidence-Based Clinical Pathway Changes Physician Patterns in Care for Bone Metastases

11/09/2015

JCP Editors

Implementing a clinical pathway to standardize care for cancer patients experiencing bone metastases may help change physician behavior and reduce the number of painful radiation therapies used in treatment,...

...

11/09/2015

Journal of Clinical Pathways